Genprex (GNPX) Competitors

LianBio (NASDAQ:LIAN) and Genprex (NASDAQ:GNPX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

Does the MarketBeat Community believe in LIAN or GNPX?

Genprex received 195 more outperform votes than LianBio when rated by MarketBeat users. Likewise, 65.25% of users gave Genprex an outperform vote while only 36.36% of users gave LianBio an outperform vote.

Company	Underperform	Outperform
LianBio	Outperform Votes 4 36.36%	Underperform Votes 7 63.64%
Genprex	Outperform Votes 199 65.25%	Underperform Votes 106 34.75%

Which has more risk & volatility, LIAN or GNPX?

LianBio has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Comparatively, Genprex has a beta of -0.4, meaning that its stock price is 140% less volatile than the S&P 500.

Does the media favor LIAN or GNPX?

In the previous week, Genprex had 5 more articles in the media than LianBio. MarketBeat recorded 6 mentions for Genprex and 1 mentions for LianBio. LianBio's average media sentiment score of 0.75 beat Genprex's score of 0.28 indicating that LianBio is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LianBio	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Genprex	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders and institutionals have more ownership in LIAN or GNPX?

74.8% of LianBio shares are held by institutional investors. Comparatively, 14.1% of Genprex shares are held by institutional investors. 7.6% of LianBio shares are held by company insiders. Comparatively, 8.5% of Genprex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has preferable earnings & valuation, LIAN or GNPX?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LianBio	N/A	N/A	-$110.29M	-$0.81	-0.25
Genprex	N/A	N/A	-$30.86M	N/A	N/A

Is LIAN or GNPX more profitable?

LianBio's return on equity of -33.17% beat Genprex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LianBio	N/A	-33.17%	-30.19%
Genprex	N/A	-409.48%	-269.17%

Do analysts recommend LIAN or GNPX?

Genprex has a consensus target price of $10.00, suggesting a potential upside of 3,458.72%. Given Genprex's stronger consensus rating and higher possible upside, analysts clearly believe Genprex is more favorable than LianBio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LianBio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Genprex	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Genprex beats LianBio on 8 of the 13 factors compared between the two stocks.